Quick Answer
Virax Biolabs Group Ltd reported Total Assets of $6.43 million for the year ending 2025.
- Virax Biolabs Group Ltd showed an increase of +17.2% in Total Assets from 2024 to 2025.
- This data is from Virax Biolabs Group Ltd's annual report (Form 10-K), filed with the SEC on July 2, 2025.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 5 years of available data (2021 to 2025), Virax Biolabs Group Ltd's Total Assets has grown by 16,121.0%.
- Historical annual values: Fiscal year 2025: $6.43 million | Fiscal year 2024: $5.48 million | Fiscal year 2023: $9.81 million | Fiscal year 2022: $48.7 thousand | Fiscal year 2021: $39.6 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: